Key Points
- Director Lawrence Kurzius purchased 10,000 Cooper Companies shares for approximately $549,300, increasing his direct ownership by 47.4% to 31,099 shares. He also bought another 10,000 shares earlier in the week.
- Cooper Companies exceeded quarterly EPS expectations, reporting $1.15 versus the $1.12 consensus, but revenue of $1.07 billion fell short of estimates. The company also authorized a $3 billion share buyback covering up to 22.7% of outstanding shares.
- Analyst sentiment remains cautious, with an average rating of “Hold” and multiple firms lowering price targets amid weaker contact-lens demand, distributor inventory reductions and activist pressure for management changes.
The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) Director Lawrence Kurzius purchased 10,000 shares of the stock in a transaction on Wednesday, September 16th. The shares were purchased at an average cost of $54.93 per share, for a total transaction of $549,300.00. Following the acquisition, the director directly owned 31,099 shares of the company's stock, valued at approximately $1,708,268.07. This represents a 47.40% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Lawrence Erik Kurzius also recently made the following trade(s):
- On Monday, September 14th, Lawrence Kurzius acquired 10,000 shares of Cooper Companies stock. The stock was purchased at an average cost of $53.91 per share, with a total value of $539,100.00.
Cooper Companies Stock Performance
Shares of NASDAQ COO opened at $53.78 on Friday. The stock has a market cap of $10.23 billion, a PE ratio of 18.35, a price-to-earnings-growth ratio of 2.22 and a beta of 0.82. The Cooper Companies, Inc. has a 1 year low of $51.01 and a 1 year high of $89.83. The firm has a fifty day moving average price of $70.23 and a 200-day moving average price of $68.77. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 0.73.
Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Wednesday, September 9th. The medical device company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.12 by $0.03. The company had revenue of $1.07 billion for the quarter, compared to analysts' expectations of $1.10 billion. Cooper Companies had a net margin of 13.46% and a return on equity of 10.90%. Cooper Companies's revenue for the quarter was up .5% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.49 EPS. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. Equities analysts anticipate that The Cooper Companies, Inc. will post 4.53 earnings per share for the current fiscal year.
Cooper Companies announced that its board has approved a share buyback plan on Wednesday, September 9th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the medical device company to purchase up to 22.7% of its shares through open market purchases. Shares buyback plans are typically an indication that the company's leadership believes its shares are undervalued.
Analysts Set New Price Targets
Several research firms recently issued reports on COO. JPMorgan Chase & Co. cut their target price on Cooper Companies from $71.00 to $58.00 and set a "neutral" rating for the company in a research report on Thursday, September 10th. KeyCorp reissued a "sector weight" rating on shares of Cooper Companies in a report on Friday, June 5th. William Blair cut Cooper Companies from an "outperform" rating to a "market perform" rating in a report on Thursday, September 10th. BNP Paribas Exane dropped their price target on Cooper Companies from $95.00 to $92.00 and set an "outperform" rating for the company in a research note on Monday, June 8th. Finally, Wells Fargo & Company set a $61.00 price objective on shares of Cooper Companies and gave the company an "equal weight" rating in a report on Thursday, September 10th. Five analysts have rated the stock with a Buy rating, eleven have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and an average target price of $71.47.
View Our Latest Stock Analysis on COO
Hedge Funds Weigh In On Cooper Companies
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in COO. Avalon Trust Co purchased a new stake in Cooper Companies during the second quarter valued at approximately $25,000. Root Financial Partners LLC boosted its holdings in shares of Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company's stock worth $26,000 after purchasing an additional 162 shares during the period. SJS Investment Consulting Inc. increased its position in shares of Cooper Companies by 107.5% during the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company's stock valued at $26,000 after purchasing an additional 187 shares during the last quarter. Elevation Wealth Partners LLC increased its position in shares of Cooper Companies by 1,136.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company's stock valued at $29,000 after purchasing an additional 375 shares during the last quarter. Finally, Continuum Advisory LLC purchased a new stake in Cooper Companies during the 2nd quarter valued at $30,000. 24.39% of the stock is owned by institutional investors.
Key Headlines Impacting Cooper Companies
Here are the key news stories impacting Cooper Companies this week:
- Positive Sentiment: Director Lawrence Kurzius purchased 10,000 shares for approximately $549,300, increasing his position by 47.4%. Other directors, including Paul Keel and Walter Rosebrough Jr., also recently bought shares. The purchases may provide a modest confidence signal from insiders after the selloff. Insider purchase report
- Neutral Sentiment: Jana Partners is pressing Cooper to replace its chief executive and pursue an urgent overhaul, citing “chronic underperformance.” The activist campaign could create a catalyst for strategic change, but it also increases leadership and execution uncertainty. Wall Street Journal activist report
- Negative Sentiment: Cooper’s latest quarterly results beat adjusted EPS expectations, $1.15 versus $1.12, but revenue of approximately $1.07 billion missed the $1.10 billion consensus. Management also reduced fiscal 2026 adjusted EPS guidance to $4.51–$4.55 and revenue guidance to $4.23–$4.25 billion, reflecting weaker contact-lens demand.
- Negative Sentiment: Reports that U.S. distributors are reducing channel inventories have raised concerns about near-term sales and whether the weakness reflects temporary destocking or softer underlying demand. Inventory destocking report
- Negative Sentiment: Pomerantz, Bragar Eagel & Squire, and Levi & Korsinsky announced investigations into potential securities claims. These notices do not establish wrongdoing, but they add legal and headline risk. Analysts have also lowered their consensus price target to about $72.27. Pomerantz investigation
Cooper Companies Company Profile
(
Get Free Report)
Cooper Companies, Inc is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company develops, manufactures and markets products through two primary business segments: CooperVision and CooperSurgical.
CooperVision specializes in contact lenses, including daily disposable, toric, multifocal, multifocal toric, specialty and myopia-management lenses. Its products are designed to address a range of vision-correction needs, including astigmatism, presbyopia and irregular corneas.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
